Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ICUNASDAQ:LNSRNASDAQ:NMTCNYSE:VAPO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICUSeaStar Medical$0.41-3.5%$1.12$0.31▼$13.85$4.54M-0.891.50 million shs2.85 million shsLNSRLENSAR$12.76+1.7%$13.43$3.50▼$17.31$150.47M0.5290,721 shs1.33 million shsNMTCNeuroOne Medical Technologies$0.68-6.8%$0.63$0.40▼$1.39$33.88M0.63186,184 shs138,518 shsVAPOVapotherm$2.17$2.16$0.70▼$3.44$13.58M-1.11N/A51,531 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICUSeaStar Medical-3.52%+14.92%-65.38%-76.17%-94.64%LNSRLENSAR+1.67%+2.82%-6.04%-9.70%+190.66%NMTCNeuroOne Medical Technologies-6.85%+3.03%+7.14%-20.93%+0.73%VAPOVapotherm0.00%0.00%0.00%0.00%+1.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationICUSeaStar MedicalN/AN/AN/AN/AN/AN/AN/AN/ALNSRLENSAR1.2903 of 5 stars2.03.00.00.02.22.50.0NMTCNeuroOne Medical Technologies3.0451 of 5 stars3.55.00.00.02.81.70.0VAPOVapothermN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICUSeaStar Medical 0.00N/AN/AN/ALNSRLENSAR 2.00Hold$15.0017.55% UpsideNMTCNeuroOne Medical Technologies 3.00Buy$1.45113.24% UpsideVAPOVapotherm 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VAPO, ICU, NMTC, and LNSR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/5/2025NMTCNeuroOne Medical TechnologiesLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.45(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICUSeaStar Medical$140K32.41N/AN/A($0.34) per share-1.19LNSRLENSAR$53.49M2.81N/AN/A$0.42 per share30.38NMTCNeuroOne Medical Technologies$3.45M9.82N/AN/A$0.03 per share22.67VAPOVapotherm$68.67M0.20N/AN/A($9.01) per share-0.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICUSeaStar Medical-$24.83M-$3.47N/A∞N/AN/AN/A-313.28%8/12/2025 (Estimated)LNSRLENSAR-$31.40M-$4.85N/A∞N/A-99.17%-737.30%-81.69%8/6/2025 (Estimated)NMTCNeuroOne Medical Technologies-$12.32M-$0.22N/A∞N/A-75.41%-334.64%-124.42%8/13/2025 (Estimated)VAPOVapotherm-$58.19M-$8.51N/A∞N/A-76.74%N/A-68.08%N/ALatest VAPO, ICU, NMTC, and LNSR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025ICUSeaStar Medical-$0.52-$0.44+$0.08-$0.44$0.15 million$0.29 million5/13/2025Q2 2025NMTCNeuroOne Medical Technologies-$0.09-$0.07+$0.02-$0.07$1.27 billion$1.39 billion5/8/2025Q1 2025LNSRLENSAR-$0.1550-$2.32-$2.1650-$2.32$13.40 million$11.53 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthICUSeaStar MedicalN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/AVAPOVapothermN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICUSeaStar MedicalN/A0.960.96LNSRLENSARN/A1.811.25NMTCNeuroOne Medical TechnologiesN/A2.131.09VAPOVapothermN/A0.250.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICUSeaStar Medical1.69%LNSRLENSAR40.15%NMTCNeuroOne Medical Technologies16.07%VAPOVapotherm43.08%Insider OwnershipCompanyInsider OwnershipICUSeaStar Medical1.30%LNSRLENSAR38.52%NMTCNeuroOne Medical Technologies8.90%VAPOVapotherm15.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICUSeaStar Medical211.20 million11.06 millionNot OptionableLNSRLENSAR11011.79 million7.25 millionOptionableNMTCNeuroOne Medical Technologies2049.82 million45.38 millionOptionableVAPOVapotherm2906.26 million5.27 millionNo DataVAPO, ICU, NMTC, and LNSR HeadlinesRecent News About These CompaniesNew Study Confirms Vapotherm's Unicorn™ Cannula Provides Comparable Efficacy at Lower Flow RatesMay 20, 2025 | finance.yahoo.comGlobal High-Flow Oxygen Therapy Devices Market Set to Reach USD 1,567.2 Million by 2033 Amid Rising Demand for Respiratory Care Solutions | FMIOctober 25, 2024 | fmiblog.comFGlobal Active Humidifier Devices Market Projects Modest Decline Amid Shifting Respiratory Care Landscape | FMIOctober 25, 2024 | fmiblog.comFDecline Looms Over Global High Flow Nasal Cannula Market to reach USD 1,063.0 Million by 2034: A Call for Innovation and Adaptation | FMIOctober 21, 2024 | fmiblog.comFGlobal Endobronchial Valves Market Expected to Experience Strong Growth by 2031 | Exactitude ConsultancySeptember 24, 2024 | finance.yahoo.comVapotherm, Inc.: Vapotherm Announces Closing of MergerSeptember 20, 2024 | finanznachrichten.deVapotherm Announces Closing of MergerSeptember 20, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VAPO, SGE, RPHM, SQSP on Behalf of ShareholdersAugust 30, 2024 | stockhouse.comVAPO Stock Earnings: Vapotherm Reported Results for Q2 2024August 13, 2024 | msn.comVapotherm Reports Second Quarter 2024 Financial ResultsAugust 12, 2024 | prnewswire.comPLPL Plandaí Biotechnology, Inc.July 28, 2024 | seekingalpha.comVA20.SG,0P0001F4D7,0 (VA20.SG)July 23, 2024 | finance.yahoo.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. - VAPOJuly 9, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. – VAPOJuly 8, 2024 | globenewswire.comThe Schall Law Firm Is Performing A Scrutiny Into Vapotherm Inc And Welcomes Investors Of VAPO To EngageJuly 1, 2024 | accesswire.comAThe Schall Law Firm Is Carrying Out An Inquiry Into Vapotherm Inc And Requests Investors Of VAPO To Be Part Of ItJune 30, 2024 | accesswire.comAThe Schall Law Firm Is Undertaking An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To JoinJune 29, 2024 | accesswire.comAThe Schall Law Firm Is Leading An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To JoinJune 28, 2024 | accesswire.comAThe Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages VAPO Investors To ParticipateJune 27, 2024 | accesswire.comAThe Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages Investors Of VAPO To ParticipateJune 26, 2024 | accesswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense3 Industrials Stocks Standing Out for Growth and Analyst OptimismBy Nathan Reiff | June 4, 2025View 3 Industrials Stocks Standing Out for Growth and Analyst OptimismWhich U.S. Towns See Economic Change First? [2025 Survey]By MarketBeat Staff | June 9, 2025View Which U.S. Towns See Economic Change First? [2025 Survey]VAPO, ICU, NMTC, and LNSR Company DescriptionsSeaStar Medical NASDAQ:ICU$0.41 -0.01 (-3.52%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.41 +0.00 (+1.21%) As of 06/27/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.LENSAR NASDAQ:LNSR$12.76 +0.21 (+1.67%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$12.76 0.00 (0.00%) As of 06/27/2025 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.NeuroOne Medical Technologies NASDAQ:NMTC$0.68 -0.05 (-6.85%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.73 +0.05 (+7.35%) As of 06/27/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.Vapotherm NYSE:VAPOVapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Broadcom’s Big VMware Update: A Threat to Public Cloud Giants? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
